News FDA chooses flu vaccine strains despite cancelled meeting The FDA has released its recommendations on the composition of influenza vaccines for the 2025-26 season – without the input of its external advisors.
News Trump pulls CDC head nomination as FDA, CDC picks advance President Trump has withdrawn his nomination of Dave Weldon to lead the CDC, hours before he was to appear in front of a Senate confirmation hearing.
News FDA Commissioner pick Makary pressed by Senators on vaccines President Trump's pick to lead the FDA, Martin Makary, was challenged on vaccines, the abortion pill, and FDA staffing decisions at a Senate hearing.
News FDA starts review of Roche's Gazyva in lupus nephritis FDA starts a review of Roche's Gazyva as a treatment for lupus nephritis, an indication that analysts think could unlock renewed sales growth.
News Vaccine sector on edge as HHS cancels flu meeting An FDA advisory committee due to be held in March to discuss the formulation of influenza vaccines for the 2025/26 flu season has been cancelled.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.